The most consequential force in food right now is not a celebrity chef or a viral recipe. It is a class of medication. About one in eight U.S. adults is currently taking a GLP-1 drug such as Ozempic or Zepbound, and the way those millions of people eat is sending shockwaves through the entire food industry.
The shift is happening quietly, on grocery shelves and restaurant menus, but its scale is enormous. By 2030, more than 30 million Americans could be on a GLP-1 treatment, up from roughly 10 million in 2026. Food companies are racing to understand what that means and to stay relevant to a customer whose appetite has fundamentally changed.
Smaller Appetites, Bigger Questions
GLP-1 drugs work in part by curbing appetite, and the effect on eating behavior is measurable. Dinner traffic has fallen about 6% among consumers who take the medication regularly, contributing to a roughly 0.4% decline in overall restaurant sales during dinner hours.
The financial stakes for the broader industry are striking. By some estimates, the growing use of these medications could erase tens of billions of dollars in annual food and beverage sales as soon as 2030. When customers eat less and snack less, the math behind a century of food marketing starts to wobble.
Protein Becomes the Star Ingredient
If appetite is shrinking, one nutrient is surging: protein. GLP-1 users are advised to prioritize protein to preserve muscle while losing weight, and that guidance has ignited demand across nearly every category.
The numbers tell the story:
- Foods carrying protein claims are growing at more than 7% annually, while products without a protein angle remain stuck in low single digits
- Retail growth has hit roughly 6.8% for protein bars, 7.2% for sports powders, and 7.4% for ready-to-drink protein beverages
- Protein is now appearing in products that never carried the claim before, from snacks to baked goods to drinks
The phrase "everything has protein now" has become a running joke, but it reflects a genuine reformulation wave sweeping through the industry.
The Reformulation Race
Behind the scenes, food makers are retooling at a remarkable pace. By some accounts, more than 60% of food and beverage activity now involves some form of reformulation aimed at GLP-1 consumers.
Brands are responding in several ways:
- Labeling products as GLP-1 friendly to signal relevance to medicated shoppers
- Shrinking serving sizes to match smaller appetites
- Emphasizing protein and fiber content on the front of the package
- Shifting into beverages with hydration-focused and functional formats
Two Kinds of Consumers Emerge
The trend is also splitting the market into two distinct groups. On one side are the GLP-1 users themselves, eating less and seeking nutrient-dense, high-protein options that make every smaller bite count. On the other are consumers who are not on the drugs but have absorbed the cultural message that protein equals health, and who are buying the same products for different reasons.
This dual audience is part of why the protein boom has legs beyond the medication itself. The health framing has gone mainstream, pulling along shoppers who simply want to eat in a way that feels intentional.
What It Means for How We Cook and Eat
For home cooks and diners, the practical effects are already visible. Restaurant menus increasingly feature protein-forward dishes and lighter, smaller portions designed for guests who want quality over quantity. Functional ingredients and clearly labeled nutrition are becoming the norm rather than the exception.
It also signals a broader cultural recalibration around food and fullness. For decades, the industry optimized for crave-ability and ever-larger portions. The GLP-1 era is nudging it in the opposite direction, toward food that satisfies with less.
A Slow-Motion Transformation
None of this is happening overnight, and the long-term effects are still unfolding. But the direction is unmistakable. A pharmaceutical breakthrough has become one of the most powerful trends in modern food, reshaping what brands make, how restaurants plate, and what millions of Americans put on their forks. The protein boom is just the most visible sign of a much deeper shift in how the country thinks about eating.
